ALGS Next Earnings Date Notes

— Aligos Therapeutics (ALGS) is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver diseases & viral infections, with a particular emphasis on chronic hepatitis B (CHB) and nonalcoholic steatohepatitis (NASH). The company leverages its expertise in oligonucleotide and small molecule chemistry to design therapies aimed at functionally curing CHB & treating NASH, which remain areas with significant gaps in treatment options. For investors, the most important business metrics to monitor are pipeline progress (including clinical trial enrollment, milestones, and updated efficacy/safety data), partnership & collaboration revenues, research & development expenditures, and cash runway. Success in advancing key candidates through Phase 1 & 2 trials, securing collaborations or licensing deals, as well as updates on regulatory interactions, are significant indicators of future value creation. During the upcoming earnings call, pay particular attention to management's commentary on candidate timelines, interim data readouts, cash burn, and strategic outlook, as these factors will help gauge Aligos’ long-term growth trajectory & potential for delivering breakthrough therapies in liver disease. The next projected earnings date for ALGS is 8/5/2026 after close (stay tuned for a confirmed earnings date once announced).

ALGS Next Earnings Date FAQ

On this page we presented the ALGS Next Earnings Date information for Aligos Therapeutics along with recent past earnings dates. For Q1 of 2026, ALGS reported earnings of -2.210/share, with the earnings report taking place on 5/7/2026. For Q4 of 2025, ALGS reported earnings of -1.910/share, with the earnings report taking place on 3/5/2026. For Q3 of 2025, ALGS reported earnings of -3.040/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, ALGS reported earnings of -1.530/share, with the earnings report taking place on 8/6/2025. For Q1 of 2025, ALGS reported earnings of -2.110/share, with the earnings report taking place on 5/6/2025. Based on these past earnings dates, the projected next earnings date for ALGS is 8/5/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Aligos Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Aligos Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Aligos Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next ALGS earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up ALGS's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the ALGS next earnings date.